Manulife (Manufacturers Life Insurance)’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-72,380
| Closed | -$297K | – | 3254 |
|
|
2022
Q1 | $297K | Sell |
72,380
-19,794
| -21% | -$71.8K | ﹤0.01% | 2521 |
|
|
2021
Q4 | $329 | Sell |
92,174
-373
| -0.4% | -$1.3K | ﹤0.01% | 2546 |
|
|
2021
Q3 | $337K | Sell |
92,547
-5,714
| -6% | -$23.1K | ﹤0.01% | 2579 |
|
|
2021
Q2 | $428K | Buy |
98,261
+1,813
| +2% | +$7.39K | ﹤0.01% | 2552 |
|
|
2021
Q1 | $396K | Sell |
96,448
-3,544
| -4% | -$15.4K | ﹤0.01% | 2441 |
|
|
2020
Q4 | $399K | Sell |
99,992
-138
| -0.1% | -$446 | ﹤0.01% | 2336 |
|
|
2020
Q3 | $270K | Hold |
100,130
| – | – | ﹤0.01% | 2365 |
|
|
2020
Q2 | $269K | Sell |
100,130
-4,753
| -5% | -$13.3K | ﹤0.01% | 2326 |
|
|
2020
Q1 | $248K | Buy |
104,883
+6,583
| +7% | +$22.4K | ﹤0.01% | 2202 |
|
|
2019
Q4 | $462K | Sell |
98,300
-5,343
| -5% | -$21.9K | ﹤0.01% | 2094 |
|
|
2019
Q3 | $358K | Sell |
103,643
-425
| -0.4% | -$1.4K | ﹤0.01% | 2212 |
|
|
2019
Q2 | $342K | Buy |
104,068
+6,834
| +7% | +$19.8K | ﹤0.01% | 2286 |
|
|
2019
Q1 | $295K | Sell |
97,234
-6,778
| -7% | -$22K | ﹤0.01% | 2276 |
|
|
2018
Q4 | $282K | Buy |
104,012
+59,525
| +134% | +$196K | ﹤0.01% | 2188 |
|
|
2018
Q3 | $149K | Sell |
44,487
-74,220
| -63% | -$229K | ﹤0.01% | 2835 |
|
|
2018
Q2 | $306K | Buy |
118,707
+2,764
| +2% | +$6.88K | ﹤0.01% | 2770 |
|
|
2018
Q1 | $256K | Sell |
115,943
-2,903
| -2% | -$6.53K | ﹤0.01% | 2830 |
|
|
2017
Q4 | $237K | Sell |
118,846
-1,057
| -0.9% | -$2.3K | ﹤0.01% | 2876 |
|
|
2017
Q3 | $389K | Sell |
119,903
-1,730
| -1% | -$5.34K | ﹤0.01% | 2452 |
|
|
2017
Q2 | $392K | Buy |
121,633
+112,191
| +1,188% | +$318K | ﹤0.01% | 2479 |
|
|
2017
Q1 | $27K | Buy |
9,442
+8,287
| +717% | +$19.9K | ﹤0.01% | 3481 |
|
|
2016
Q4 | $3K | Hold |
1,155
| – | – | ﹤0.01% | 4068 |
|
|
2016
Q3 | $2K | Hold |
1,155
| – | – | ﹤0.01% | 4092 |
|
|
2016
Q2 | $1K | Sell |
1,155
-106,206
| -99% | -$103K | ﹤0.01% | 4173 |
|
|
2016
Q1 | $92K | Buy |
107,361
+2,971
| +3% | +$2.88K | ﹤0.01% | 3084 |
|
|
2015
Q4 | $126 | Buy |
104,390
+300
| +0.3% | +$418 | ﹤0.01% | 2985 |
|
|
2015
Q3 | $177 | Buy |
104,090
+2,028
| +2% | +$3.98K | ﹤0.01% | 2747 |
|
|
2015
Q2 | $213 | Buy |
102,062
+18,873
| +23% | +$45.8K | ﹤0.01% | 2800 |
|
|
2015
Q1 | $225 | Buy |
83,189
+3,105
| +4% | +$7.88K | ﹤0.01% | 2647 |
|
|
2014
Q4 | $206 | Sell |
80,084
-484
| -0.6% | -$1.09K | ﹤0.01% | 2622 |
|
|
2014
Q3 | $147 | Buy |
80,568
+3,070
| +4% | +$6.69K | ﹤0.01% | 2853 |
|
|
2014
Q2 | $207K | Sell |
77,498
-10,756
| -12% | -$32.4K | ﹤0.01% | 2688 |
|
|
2014
Q1 | $309 | Sell |
88,254
-785
| -0.9% | -$3.48K | ﹤0.01% | 2414 |
|
|
2013
Q4 | $399 | Sell |
89,039
-3,958
| -4% | -$16.1K | ﹤0.01% | 2221 |
|
|
2013
Q3 | $377 | Sell |
92,997
-3,416
| -4% | -$14.9K | ﹤0.01% | 2176 |
|
|
2013
Q2 | $401K | Buy |
+96,413
| New | +$372K | ﹤0.01% | 2037 |
|
Other funds holding ATRS
Manulife (Manufacturers Life Insurance)'s ATRS Position: Q2 2022 in Review
Manulife (Manufacturers Life Insurance) sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 72,380 shares — an estimated $297K sold.
Manulife (Manufacturers Life Insurance) first reported a position in ATRS in Q2 2013 and held it in 36 quarters. The position peaked at $462K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Manulife (Manufacturers Life Insurance) reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 72,380 Antares Pharma, Inc. shares in Q2 2022, an estimated $297K.
- Manulife (Manufacturers Life Insurance) first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 36 quarters.
- Manulife (Manufacturers Life Insurance)'s Antares Pharma, Inc. position peaked at $462K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.